| 发明名称 |
PHARMACEUTICAL COMPOSITION |
| 摘要 |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing a piperidine compound having excellent tachykinin receptor antagonistic activity as an active component. SOLUTION: The pharmaceutical composition contains a piperidine compound expressed by general formula [I] or its pharmacologically allowable salt as an active component. In the formula, the ring A is a benzene ring optionally having a substituent; the ring B is a benzene ring optionally having a substituent; R<SP>1</SP>is a hydrogen atom or a substituent for an amino group; R<SP>2</SP>is a hydrogen atom, a (substituted)hydroxy group or the like; Z is an oxygen atom or a group expressed by -N(R<SP>3</SP>)-; R<SP>3</SP>is a hydrogen atom or a (substituted)alkyl group; R<SP>4a</SP>and R<SP>4b</SP>are each independently a hydrogen atom or a (substituted)alkyl group or both groups may be bonded together at the terminals to form an alkylene group. COPYRIGHT: (C)2007,JPO&INPIT
|
| 申请公布号 |
JP2007197428(A) |
申请公布日期 |
2007.08.09 |
| 申请号 |
JP20060349025 |
申请日期 |
2006.12.26 |
| 申请人 |
TANABE SEIYAKU CO LTD |
发明人 |
MIYAKE TSUTOMU;YAMANAKA TAKESHI;TERAKAWA YOSHIHIRO;ASAI HIDETOSHI |
| 分类号 |
A61K31/445;A61K31/4523;A61K31/4525;A61K31/453;A61K31/4535;A61K31/454;A61K31/4545;A61K31/496;A61K31/506;A61K31/5377;A61K31/541;A61P1/00;A61P1/08;A61P9/00;A61P11/00;A61P13/02;A61P17/04;A61P25/00;A61P25/04;A61P25/06;A61P29/00;A61P37/00;A61P43/00;C07D211/62;C07D401/06;C07D401/14;C07D405/06;C07D409/06;C07D413/06 |
主分类号 |
A61K31/445 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
